Fundraising Fox
/Companies
Sign in

CollimateHealth

Founded 2026 · 11 employees on LinkedIn · 5 known investors

Find your way into CollimateHealth

Sign up to see every warm intro you have to CollimateHealth

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the CollimateHealth team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

CollimateHealth develops a clinically scalable microbeam radiation technology for cancer treatment, delivering arrays of narrow, micrometer-scale radiation beams at higher doses than conventional broad-beam radiation oncology. The technology aims to trigger immune responses against cancer cells and improve delivery of chemotherapy and immunotherapy into tumor tissue.

BiotechHealthtechMedical Devices

Founders & leadership

CollimateHealth was founded in 2026 by Stefan Bartzsch, Johanna Winter, and Hans Maria Heÿn.

SB
Stefan BartzschCo-founder & Chief Scientific Officer
JW
Johanna WinterCo-founder & Chief Technology Officer
HMHans Maria Heÿn
Hans Maria HeÿnCo-founder & Chief Executive OfficerCo-founder and CEO of CollimateHealth, which develops a clinically scalable microbeam radiation technology for cancer treatment. He has over 15 years of experience in in-vitro diagnostics, medical device, and health-tech development, including MDR and IVDR regulatory requirements and leading international product development teams.

Investors · 5

xista science ventureslisted by xista science venturesKlosterneuburg · $162K – $4.3M

How we know: xista science ventures's portfolio page · pulse2.com · Not right? Tell us

Caesar VenturesreportedBerlin

How we know: pulse2.com · Not right? Tell us

HTGFreportedBonn · $1.1M

How we know: pulse2.com · funding news · Not right? Tell us

Also in the syndicate · 1

VP Venture Partners

Funding

SEC filings, press & company announcements

Source: company announcements and press reports — follow each round's link for the claim.

In the news

HTGF and VP Venture Partners back CollimateHealth's €6M bet that hair-thin radiation beams can out-compete chemotherapy — TFNtechfundingnews.com · Jun 2026CollimateHealth Raises €6M in Seed Fundingfinsmes.com · Jun 2026

Frequently asked questions

What does CollimateHealth do?
CollimateHealth develops a clinically scalable microbeam radiation technology for cancer treatment, delivering arrays of narrow, micrometer-scale radiation beams at higher doses than conventional broad-beam radiation oncology. The technology aims to trigger immune responses against cancer cells and improve delivery of chemotherapy and immunotherapy into tumor tissue.
Who founded CollimateHealth?
CollimateHealth was founded by Stefan Bartzsch, Johanna Winter, Hans Maria Heÿn in 2026.
Who are CollimateHealth's investors?
CollimateHealth's investors include Positron Ventures, xista science ventures, Caesar Ventures, HTGF.